OpGen | 10-Q: FY2025 Q2 Revenue: USD 4 M

Revenue: As of FY2025 Q2, the actual value is USD 4 M.

EPS: As of FY2025 Q2, the actual value is USD 0.34.

EBIT: As of FY2025 Q2, the actual value is USD 3.296 M.

Segment Revenue

• Listing Sponsorship Services: Revenue for the three and six months ended June 30, 2025, was $4,000,000, compared to $28,000 and $196,149 for the same periods in 2024, respectively.

Operational Metrics

• Net Income: For the three months ended June 30, 2025, net income was $3,509,992, compared to a net loss of - $1,576,349 for the same period in 2024. For the six months ended June 30, 2025, net income was $3,101,859, compared to a net loss of - $1,288,382 for the same period in 2024.
• Operating Income (Loss): Operating income for the three months ended June 30, 2025, was $3,402,775, compared to an operating loss of - $1,547,310 for the same period in 2024. For the six months ended June 30, 2025, operating income was $2,879,929, compared to an operating loss of - $3,292,625 for the same period in 2024.

Cash Flow

• Net Cash Used in Operating Activities: For the six months ended June 30, 2025, net cash used in operating activities was - $645,337, compared to - $1,804,262 for the same period in 2024.
• Net Cash Provided by Financing Activities: For the six months ended June 30, 2025, net cash provided by financing activities was $166,318, compared to $820,553 for the same period in 2024.

Unique Metrics

• Accounts Receivable: As of June 30, 2025, accounts receivable from one customer represented 99% of total accounts receivable.

Future Outlook and Strategy

• Core Business Focus: The company plans to continue its focus on listing sponsorship and consultancy services through its subsidiary CapForce, and anticipates generating revenues from cross-border securities trading and digital investment banking activities.
• Non-Core Business: The company has repositioned itself from its legacy operations in precision medicine to focus on financial services and technology, including a joint venture with the European Credit Investment Bank to develop a stock trading platform and digital investment banking platform.